Bill Texts: VA SB614 | 2024 | Regular Session

Bill Title: Xylazine; penalty for manufacturing, selling, etc., for human consumption.

Spectrum: Partisan Bill (Republican 2-0)

Status: (Passed) 2024-04-04 - Governor: Acts of Assembly Chapter text (CHAP0516) [SB614 Detail]

Bill Drafts

RevisionDateFormatSourceView
Chaptered2024-04-04HTML/TextLinkView
Enrolled2024-02-29HTML/TextLinkView
Comm Sub2024-02-01HTML/TextLinkView
Prefiled2024-01-10HTML/TextLinkView

Amendments

AmendmentDateDispositionFormatSourceView
Substitute for SB614 S-Education and Health, Health Professions2024-01-26ProposedPDFLinkView

Supplemental Documents

TitleDescriptionDateFormatSourceView
Fiscal Note/AnalysisSenate: Prefiled and ordered printed; offered 01/10/24 24104627D2024-01-12PDFLinkView
Fiscal Note/AnalysisSenate: Impact statement from DPB (SB614)2024-01-25PDFLinkView
Fiscal Note/AnalysisSenate: Impact statement from VCSC (SB614S1)2024-02-02PDFLinkView
Fiscal Note/AnalysisSenate: Impact statement from DPB (SB614S1)2024-02-05PDFLinkView
Fiscal Note/AnalysisSenate: Bill text as passed Senate and House (SB614ER)2024-02-29PDFLinkView

Social Comments on VA SB614

feedback